EN DE
Watch Wellnex Life Limited for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Wellnex Life Limited (WNX) fair value: what the stock is really worth

As of Nov 9, 2026: fair value (intrinsic value) of Wellnex Life Limited stock £0.04, price £0.05, that is 10.7% below the price, quality 29 out of 100. Rating: overvalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive GB · Home Australia · ISIN AU0000162281

WL Wellnex Life Limited logo Thin data Oct 30, 2026

Wellnex Life Limited

WNX · LSE
Weak valuation

Our calculation puts a fair price 11% below what the stock costs today.

Fair value £0.0402 · Overvalued
Quality 29/100
Weak Growth (revenue 3y −3.8 %/yr in AUD)
Loss-making · -18.3% net margin (TTM)
Negative free cash flow
Trails peers (2/9)
Narrow moat 5/100 · thin data
Thin data
⚠ Dilution⚠ Thinly traded
Watch Wellnex Life Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

£0.1025 £0.0325 Fair Value £0.0402 Dec 2025 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Oct 30, 2026.

How to read this chart

11‑month range £0.0325 – £0.1025 · fair‑value band £0.0364 – £0.0479 · the £0.0450 price screens above the £0.0402 fair value. As of Oct 30, 2026.

Follow Wellnex Life in your weekly email

Every Wednesday you see whether Wellnex Life is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom.

Show moreShow less

The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand.

It is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021.

Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.

Stock analysis

Wellnex Life Limited (WNX) currently trades at £0.0450, while our model-based Fair Value estimate is £0.0402, 11% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 90/100, which puts the data coverage at low.

Scenario range: £0.0364 (bear) to £0.0479 (bull), the price of £0.0450 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 29/100 (below-average quality), in the Consumer Defensive sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Wellnex Life Limited reported revenue of A$24.8M in FY2026 versus A$1.2M in FY2021, a compound +83.5%/yr. Reported net income was −A$4.5M in FY2026.

Key figures

Market cap £3.3M Micro · P/S ratio 0.13 · EPS (TTM) £−0.0700 · Net margin −18.3% · Return on equity −48.7% · Return on assets (EBIT) −39.3% (5-year average) · Operating margin −9.2% · Revenue (TTM) A$24.8M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 5 out of 100 (low confidence).

What moves the price

The share trades about 56% below its 52-week high and 38% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −1% fair-value upside, at −11%, WNX screens richer than that median.

Fair Value models

Bear £0.0364 Fair Value £0.0402 Bull £0.0479
Price £0.0450 · Downside -10.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
NCAV (Graham) £0.0300 £0.0500 £0.0700 51
All 1 models by family
Asset-Based
NCAV (Graham) £0.0300 £0.0500 £0.0700 51

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 29/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 27
How much profit the company makes from its sales and capital
Quality Growth 90
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 21
Debt, balance sheet and risk of trouble
Investment 56
Does it invest with discipline instead of growing at any price?
Low Volatility 19
How calm the share price moves, does not count
Price momentum 21
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 9
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 36/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+83.5%
Start year 2021 (pandemic)
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−777.1% (2021) → −8.5% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

WNX screens overvalued: fair value 11% below the price. Compare with Nestlé S.A →

Compare Wellnex Life Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 625 stocks

Beats the industry median on 2/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 29 · Bottom 25%
Fair Value upside −10.7% · Below median
Profitability
Return on assets −19.1% · Bottom 25%
Net margin (12 months) −18.3% · Bottom 25%
Operating margin (12 months) −9.2% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 2.2% · Below median

Valuation Multiplesvs Packaged Foods median · lower = cheaper

P/B 0.86× · Cheaper than median
P/S (12 months) 0.26× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)19 · sector 35
FUTURE (revenue growth)11 · sector 25
PAST (return on equity)0 · sector 31
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)0 · sector 55

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wilmar International Limited F34 2.97 SGD 4.93 SGD +66% vs WNX
Inner Mongolia Yili Industrial Group 600887 ¥31.45 ¥41.84 +33% vs WNX
The Kraft Heinz Company KHC $24.61 $29.20 +19% vs WNX
Foshan Haitian Flavouring and Food Company 603288 ¥35.78 ¥39.22 +10% vs WNX
General Mills, Inc GIS $35.51 $35.30 −1% vs WNX
Danone S.A BN €67.12 €50.65 −25% vs WNX
Nestlé S.A NESN CHF 85.85 CHF 59.51 −31% vs WNX
Kerry Group KRZ €98.00 €60.33 −38% vs WNX
Nestlé India Limited NESTLEIND ₹1,282 ₹724.74 −43% vs WNX
Yihai Kerry Arawana Holdings 300999 ¥26.21 ¥12.21 −53% vs WNX

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Wellnex Life Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Wellnex Life Limited Fair Value". https://www.fairvalue-calculator.com/stock/WNX

Frequently asked questions

Is Wellnex Life Limited (WNX) overvalued or undervalued?
As of Oct 30, 2026, our model estimates a fair value of £0.0402 versus a price of £0.0450, about 11% lower (overvalued).
What is the fair value of WNX?
Our model-based fair value for Wellnex Life Limited is £0.0402 (as of Oct 30, 2026), built from audited fundamentals. The current price: £0.0450.
What is the quality score of WNX?
Wellnex Life Limited has a Quality Score of 29/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Wellnex Life Limited (WNX)?
Our model-based price target is the fair value of £0.0402 (as of Oct 30, 2026) from 1 valuation models. Cautious scenario £0.0364, optimistic scenario £0.0479. It is a calculation from audited fundamentals, not an analyst target.
What is the Wellnex Life Limited stock forecast for 2026?
Our models put fair value at £0.0402, about 11% lower versus a price of £0.0450 (overvalued). Cautious scenario £0.0364, optimistic scenario £0.0479. The calculation is refreshed regularly with new filings.
What is the revenue of Wellnex Life Limited (WNX)?
Wellnex Life Limited reported trailing-twelve-month revenue of about A$24.8M (latest available figure, as of Oct 30, 2026).
What is the intrinsic value of Wellnex Life Limited (WNX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Wellnex Life Limited it is £0.0402 per share (as of Oct 30, 2026), against a price of £0.0450. It is the blended result of 1 valuation models in 1 family (Asset-Based).
Is Wellnex Life Limited stock overvalued or undervalued in 2026?
As of Oct 30, 2026, WNX trades above its calculated fair value: price £0.0450, fair value £0.0402, a gap of about −11% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of WNX?
No. The price is what the market pays today (£0.0450); the fair value is what the company's own numbers justify (£0.0402). For Wellnex Life Limited the two are £0.0048 per share apart. That gap is exactly why we show both numbers side by side.
How much is Wellnex Life Limited worth?
The market values Wellnex Life Limited at about £3.3M (market capitalisation, as of Oct 30, 2026). Per share that is £0.0450; our models calculate a fair value of £0.0402 per share.
What do the bullish and bearish scenarios say about WNX?
Our models span a range for Wellnex Life Limited: cautious scenario £0.0364, base £0.0402, optimistic £0.0479 per share (as of Oct 30, 2026, price £0.0450). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Wellnex Life Limited (WNX)?
Balance-sheet figures for Wellnex Life Limited (as of Oct 30, 2026): return on equity −48.7%. They feed the Quality Score of 29/100, which measures business quality independently of the share price.
How far is WNX from its 52-week high?
Wellnex Life Limited trades at £0.0450, about 56% below its 52-week high of £0.1025 and 38% above the low of £0.0325 (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of £0.0402 is for.
Which stocks are comparable to Wellnex Life Limited?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Wellnex Life Limited stock attractive at the current price?
The data as of Oct 30, 2026: price £0.0450, calculated fair value £0.0402 (−11%), Quality Score 29/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of WNX calculated?
We run Wellnex Life Limited through 1 models from 1 family: Asset-Based. Every model gets the same audited fundamentals; the fair value of £0.0402 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Wellnex Life Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Wellnex Life Limited (WNX)?
The closing price on Nov 9, 2026 was £0.0450. Our model-based fair value is £0.0402, about 11% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Wellnex Life Limited right now?
Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. The price sits in the upper half of our model range, so the margin of safety is thin. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of Wellnex Life Limited

How large is the market capitalisation of Wellnex Life Limited (WNX)?
The market capitalisation of Wellnex Life Limited is £3.3M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Wellnex Life Limited (WNX)?
The price-to-sales ratio of Wellnex Life Limited is 0.13 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Wellnex Life Limited (WNX)?
Earnings per share at Wellnex Life Limited are £−0.0700. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Wellnex Life Limited (WNX)?
The net margin of Wellnex Life Limited is −18.3% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Wellnex Life Limited (WNX)?
The return on equity (ROE) of Wellnex Life Limited is −48.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Wellnex Life Limited (WNX)?
On an EBIT basis the return on assets of Wellnex Life Limited is −39.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Wellnex Life Limited (WNX)?
The operating margin of Wellnex Life Limited is −9.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Wellnex Life Limited (WNX)?
Revenue at Wellnex Life Limited is growing +2.2% versus a year earlier (3y avg +10.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Wellnex Life Limited (WNX) generate?
The free cash flow of Wellnex Life Limited is −A$2.6M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Wellnex Life Limited (WNX) carry?
The net debt of Wellnex Life Limited is A$8.9M (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Wellnex Life Limited in the live analysis

One click puts Wellnex Life Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.